Access cutting-edge liposarcoma treatment through this clinical trial at a research site in New York. Study-provided care at no cost to qualified participants.
Access liposarcoma specialists in New York at no cost
This study follows strict safety protocols and ethical guidelines
All study-related liposarcoma treatment provided free
The purpose of this study is to find out whether mirdametinib in combination with palbociclib is an effective and safe treatment for people with metastatic, recurrent, and unresectable liposarcoma. This study will test different doses of mirdametinib in combination with a fixed dose of palbociclib to find the best safe dose for further testing.
Sponsor: Memorial Sloan Kettering Cancer Center
Check if you qualify for this liposarcoma clinical trial in New York, NY
If you're searching for liposarcoma treatment options in New York, NY, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our New York research site is actively enrolling participants for this clinical trial. You'll receive care from experienced liposarcoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.